A Case of Prolonged Mania, Psychosis, and Severe Depression After Psilocybin Use: Implications of Increased Psychedelic Drug Availability

Am J Psychiatry. 2022 Dec 1;179(12):892-896. doi: 10.1176/appi.ajp.22010073.

Authors

Gregory Barber¹, Charles B Nemeroff¹, Steven Siegel¹

Affiliation

¹ Department of Psychiatry, University of Maryland School of Medicine, Baltimore (Barber); Department of Psychiatry and Behavioral Sciences, Dell Medical School, University of Texas at Austin (Nemeroff); Department of Psychiatry and Behavioral Sciences, University of Southern California, Los Angeles (Siegel).

PMID: 36453037
DOI: 10.1176/appi.ajp.22010073

No abstract available

Keywords: Hallucinogens; Pharmacotherapy; Substance-Related and Addictive Disorders.

Publication types

Case Reports

MeSH terms

Depression / drug therapy
Hallucinogens* / adverse effects
Humans
Major Depressive Disorder* / drug therapy
Mania
Psilocybin / adverse effects
Psychotic Disorders* / drug therapy
Psychotic Disorders* / etiology

Substances

Psilocybin
Hallucinogens